seed
Stage
3
Investors
About
Finnadvance develops multi-channel 3D microfluidic organ-on-chip devices and platforms for pharmaceutical companies and research organizations to model human organs and improve preclinical drug discovery while reducing animal testing.
Explore Finnadvance's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.